How long does it take for GLP-1 side effects to improve
The medication is a common cause of transient changes
Long-term success will rely on marketing, easy onboarding, support tools and adherence encouragement, and delivering consistent, trusted consumer experiences
Spironolactone plays a key role in managing PCOS symptoms by targeting androgen receptors and cutting down the production of androgens
doi: 10.1016/j.cmet.2021.12.010 Summary Keywords GIP, GLP-1, obesity, weight loss, tirzepatide, GLP-1R agonists, GIP receptor agonists, Citation Zaffina I, Pelle MC, Armentaro G, Giofr F, Cassano V, Sciacqua A and Arturi F (2023) Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity